Considerations for Design and Data Analysis of Noninferiority/Superiority Cardiovascular Trials

By Quan Hui   Li Mingyu   Zhao Peng-Liang   Cho Meehyung   Zhang Ji   Wu Yujun  

Journal of Biopharmaceutical Statistics, Vol. 23, Iss. 1, 2013-01 ,pp. : 239-260

Taylor & Francis Ltd

Access to resources Recommend Favorite

Pharmacogenetics in randomized controlled trials: considerations for trial design

By van der Baan Frederieke H   Klungel Olaf H   Egberts Antoine CG   Leufkens Hubert G   Grobbee Diederick E   Roes Kit CB   Knol Mirjam J  

Pharmacogenomics, Vol. 12, Iss. 10, 2011-10 ,pp. : 1485-1492

Future Medicine

Access to resources Recommend Favorite

Ethical Considerations in Clinical Trials

By  

Heart Drug, Vol. 1, Iss. 1, 2001-03 ,pp. : 2-4

Karger

Access to resources Recommend Favorite

A Note on Partial Covariate-Adjustment and Design Considerations in Noninferiority Trials When Patient-Level Data are not Available

By Nie Lei   Soon Guoxing (Greg)   Qi Karen   Chen Yong   Chu Haitao  

Journal of Biopharmaceutical Statistics, Vol. 23, Iss. 5, 2013-09 ,pp. : 1042-1053

Taylor & Francis Ltd

Access to resources Recommend Favorite

Clinical Trials: Design, Conduct and Analysis , Second Edition, by C. L. Meinert

By McCague Kevin  

Journal of Biopharmaceutical Statistics, Vol. 23, Iss. 2, 2013-03 ,pp. : 496-498

Taylor & Francis Ltd

Access to resources Recommend Favorite